Calvin Shaller - Concepedia

Concepedia

Author

Calvin Shaller

Fox Chase Cancer Center

Also Known As

C C Shaller, C Shaller, C. Shaller, C.C Shaller, C.C. Shaller, Calvin C. Shaller, Calvin Shaller

37

Publications

1.4K

Citations

15

H-Index

59

Concepts

All Affiliations

Fox Chase Cancer Center Hospital of the University of Pennsylvania University of California, San Francisco National Cancer Institute GE Global Research (United States)

CS

About

Calvin Shaller is an author at Fox Chase Cancer Center specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	947
2	Cell Biology	8	8	530
3	Health Sciences	4	4	350
4	Biochemistry	4	4	274
5	Natural Sciences	1	1	11

Calvin Shaller

×

20

Publications

1.4K

Citations

15

H-Index

	Year	Citations
Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors Stephen I. Rudnick, Jianlong Lou, Calvin Shaller, Cancer Research Immunocytochemical TechniqueNanotherapeuticsSolid TumorsImmunologyImmunotherapeutics	2011	344
Quantitative Immuno-Positron Emission Tomography Imaging of HER2-Positive Tumor Xenografts with an Iodine-124 Labeled Anti-HER2 Diabody Matthew K. Robinson, Mohan Doss, Calvin Shaller, Cancer Research	2005	166
Inositol 1,4,5-triphosphate-induced granule secretion in platelets. Evidence that the activation of phospholipase C mediated by platelet thromboxane receptors involves a guanine nucleotide binding protein-dependent mechanism distinct from that of thrombin. Lawrence F. Brass, Calvin Shaller, Elizabeth Belmonte Journal of Clinical Investigation Pertussis ToxinCellular PhysiologyThrombosisPlatelet Thromboxane ReceptorsHematology	1987	156
Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitro Matthew K. Robinson, Kathryn M. Hodge, Eva Horak, British Journal of Cancer ImmunologyImmunoeditingBiological TherapyImmunotherapyTumor Biology	2008	128
Delivery of the α-emitting radioisotope bismuth-213 to solid tumors via single-chain Fv and diabody molecules Gregory P. Adams, Calvin Shaller, Lara L. Chappell, Nuclear Medicine and Biology Single-chain FvTumor BiologyRadiation TherapyMedicineRadionuclide Therapy	2000	84
A Single Treatment of Yttrium-90-labeled CHX-A″–C6.5 Diabody Inhibits the Growth of Established Human Tumor Xenografts in Immunodeficient Mice Gregory P. Adams, Calvin Shaller, Ekaterina Dadachova, Cancer Research Tumor XenograftsYttrium-90-labeled Chx-a″–c6.5 DiabodyImmunologyImmunotherapyCancer Biology	2004	83
Selective loss of calcium permeability on maturation of reticulocytes. James S. Wiley, Calvin Shaller Journal of Clinical Investigation Sodium PermeabilityElectrolyte DisorderCalcium PermeabilityCytoskeletonCellular Physiology	1977	80
Effective Treatment of Established Human Breast Tumor Xenografts in Immunodeficient Mice with a Single Dose of the α-Emitting Radioisotope Astatine-211 Conjugated to Anti-HER2/<i>neu</i> Diabodies Matthew K. Robinson, Calvin Shaller, Kayhan Garmestani, Clinical Cancer Research	2008	59
Quantitation of small-animal (124)I activity distributions using a clinical PET/CT scanner. D. E. González Trotter, Ravindra M. Manjeshwar, Mohan Doss, PubMed	2004	52
Evaluation of the Anti-HER2 C6.5 Diabody as a PET Radiotracer to Monitor HER2 status and Predict Response to Trastuzumab Treatment Smitha Reddy, Calvin Shaller, Mohan Doss, Clinical Cancer Research	2010	35

Page 1